Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer

por Cherrier, M. M., Cross, D. J., Higano, C. S., Minoshima, S.
Publicado 2018

Virtual Intracavernosal Injection Training During the COVID Pandemic

por Zarowski, C, Higano, C, Wu, E, Sundar, M, Bentley, J, Flannigan, R
Publicado 2022

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T

por Small, E J, Higano, C S, Kantoff, P W, Whitmore, J B, Frohlich, M W, Petrylak, D P
Publicado 2014

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

por Bryce, A H, Alumkal, J J, Armstrong, A, Higano, C S, Iversen, P, Sternberg, C N, Rathkopf, D, Loriot, Y, de Bono, J, Tombal, B, Abhyankar, S, Lin, P, Krivoshik, A, Phung, D, Beer, T M
Publicado 2017

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or i...

por Petrylak, D.P., Vaishampayan, U.N., Patel, K.R., Higano, C.S., Albany, C., Dawson, N.A., Mehlhaff, B.A., Quinn, D.I., Nordquist, L.T., Wagner, V.J., Siegel, J., Trandafir, L., Sartor, O.
Publicado 2021